Sex-specific effects of brain LC-PUFA composition on locomotor activity in rats

Physiology and Behavior

Volumn 89, Issue 2, 2006, Pages 196-204

  Levant, Beth ^a,b   Ozias, Marlies K ^a   Carlson, Susan E ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Brain; Development; Docosahexaenoic acid; Docosapentaenoic acid; Gender; Locomotor activity; Phospholipid; Polyunsaturated fatty acid; Rat; Sex

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; BRAIN DEVELOPMENT; COGNITION; CONCEPTION; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; LIPID COMPOSITION; LOCOMOTION; MALE; NERVE CELL DIFFERENTIATION; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

EID: 33746963834     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2006.06.007     Document Type: Article

References (53)

1. Salem Jr. N., Litman B., Kim H.-Y., and Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36 (2001) 945-960
2. Uauy R., Hoffman D.C., Peirano P., Birch D.G., and Birch E.E. Essential fatty acids in visual and brain development. Lipids 36 (2001) 885-896
3. Sinclair A.J. Long chain polyunsaturated fatty acids in the mammalian brain. Proc Nutr Soc 34 (1975) 287-291
4. Fleith M., and Clandinin M.T. Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr 45 (2005) 205-229
5. McCann J.C., and Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 82 (2005) 281-295
6. Carlson S.E., and Neuringer M. Polyunsaturated fatty acid status and neurodevelopment: a summary and critical analysis of the literature. Lipids 34 (1999) 171-178
7. Wainwright P.E. Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc Nutr Soc 61 (2002) 61-69
8. Enslen M., Milon H., and Malnoe A. Effect of low intake of n-3 fatty acids during development on brain phospholipid fatty acid composition and exploratory behavior in rats. Lipids 26 (1991) 203-208
9. Levant B., Radel J.D., and Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res 152 (2004) 49-57
10. Moriguchi T., Sheaff-Greiner R., and Salem Jr. N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 75 (2000) 2563-2573
11. Sheaff-Greiner R., Moriguchi T.A.H., Slotnik B.M., and Salem N.J. Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks. Lipids 34 (1999) 239-243
12. Takeuchi T., Fukumoto Y., and Harada E. Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behav Brain Res 131 (2002) 193-203
13. Filipek P.A., Semrud-Clikeman M., Steingard R.J., Renshaw P.F., Kennedy D.N., and Biederman J. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48 (1997) 589-601
14. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch Neurol 50 (1993) 873-880
15. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148 (1991) 1474-1486
16. Weinberger D.R. Schizophrenia and the frontal lobe. Trends Neurosci 11 (1988) 367-370
17. Byne W., Kemether E., Jones L., Haroutunian V., and Davis K.L. The neurochemistry of schizophrenia. In: Charney D.S., Neslter E.J., and Bunney B.G. (Eds). Neurobiology of mental illness (1999), Oxford University Press, Oxford 236-245
18. Meltzer H.Y., and Stahl S.M. The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2 (1976) 19-76
19. Chalon S., Vancassel S., Zimmer L., Guilloteau D., and Durand G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 36 (2001) 937-944
20. Fenton W.S., Hibbeln J., and Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47 (1999) 8-21
21. Freeman M. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 12 (2000) 159-165
22. Richardson A.J., and Puri B.K. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 63 (2000) 79-87
23. National Research Council. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, D.C.
24. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951
25. Dodge J.T., and Phillips G.B. Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells. J Lipid Res 8 (1967) 667-675
26. Folch J., Lees M., and Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 497-509
27. Zail S.S., and Pickering A. Fatty acid composition of erythrocytes in hereditary spherocytosis. Br J Haematol 42 (1979) 339-402
28. Morrison W.R., and Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron trifluoride-methanol. J Lipid Res 5 (1964) 600-608
29. Carrie I., Clement M., de Javel D., Frances H., and Bourre J.M. Specific phospholipid fatty acid composition of brain regions in mice. Effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation. J Lipid Res 41 (2000) 465-472
30. Favreliere S., Barrier L., Durand G., Chalon S., and Tallineau C. Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum. Lipids 33 (1998) 401-407
31. Moriguchi T., Lim S.Y., Greiner R., Lefkowitz W., Loewke J., Hoshiba J., et al. Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats. J Lipid Res 45 (2004) 1437-1445
32. Galli C., Trzeciak H.I., and Paoletti R. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids. Biochim Biophys Acta 248 (1971) 449-454
33. Moriguchi T., Loewke J., Garrison M., Catalan J.N., and Salem Jr. N. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J Lipid Res 42 (2001) 419-427
34. Sagvolden T., and Sergeant J.A. Attention deficit/hyperactivity disorder - from brain dysfunctions to behaviour. Behav Brain Res 94 (1998) 1-10
35. Sleator E.K., and Ullmann R.K. Can the physician diagnose hyperactivity in the office?. Pediatrics 67 (1981) 13-17
36. Carpenter Jr. W.T., Conley R.R., and Buchanan R.W. Schizophrenia. In: Enna S.J., and Coyle J.T. (Eds). Pharmacological management of neurological and psychiatric disorders (1998), McGraw-Hill, New York 27-52
37. File S.E. Animal models of anxiety. In: Crawley J.N., Gerfen C.R., McKay R., Rogawski M.A., Sibley D.R., and Skolnik P. (Eds). Current protocols in neuroscience (1997), John Wiley & Sons, New York 8.3.1-8.3.15
38. Heiderstadt K.M., McLaughlin R.M., Wright D.C., Walker S.E., and Gomez-Sanchez C.E. The effect of chronic food and water restriction on open-field behaviour and serum corticosterone levels in rats. Lab Anim 34 (2000) 20-28
39. Overton J.M., and Williams T.D. Behavioral and physiologic responses to caloric restriction in mice. Physiol Behav 81 (2004) 749-754
40. Jones L.C., Bellingham W.P., and Ward L.C. Sex differences in voluntary locomotor activity of food-restricted and ad libitum-fed rats. Implications for the maintenance of a body weight set-point. Comp Biochem Physiol A 96 (1990) 287-290
41. Hall R.D. The role of body size in climbing and locomotor behavior of protein-malnourished and well-nourished rats. Dev Psychobiol 17 (1984) 91-106
42. Faracone S.V., and Biederman J. The neurobiology of attention deficit hyperactivity disorder. In: Charney D.S., Nestler E.J., and Bunny B.S. (Eds). Neurobiology of mental illness (1999), Oxford University Press, Oxford 788-809
43. Martin J.R., and Battig K. Exploratory behaviour of rats at oestrus. Anim Behav 28 Pt 3 (1980) 900-905
44. Szatmari P. The epidemiology of attention-deficit hyperactivity disorders. Child Adolesc Psychiatr Clin North Am 1 (1982) 361-371
45. Delion S., Chalon S., Guilloteau D., Besnard J.C., and Durand G. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 66 (1996) 1582-1591
46. Zimmer L., Delpal S., Guilloteau D., Aioun J., Durand G., and Chalon S. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 284 (2000) 25-28
47. Zimmer L., Durand G., Guilloteau D., and Chalon S. n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex. Lipids 34 (1999) S2519 [Suppl]
48. Zimmer L., Hembert S., Durand G., Breton P., Guilloteau D., Besnard J.C., et al. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci Lett 240 (1998) 177-181
49. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., et al. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 75 (2002) 662-667
50. Zimmer L., Delion Vancassel S., Durand G., Guilloteau D., Bodard S., Besnard J.C., et al. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41 (2000) 32-40
51. Kodas E., Vancassel S., Lejeune B., Guilloteau D., and Chalon S. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J Lipid Res 43 (2002) 1209-1219
52. Emsley R., Oosthuizen P., and van Rensburg S.J. Clinical potential of omega-3 fatty acids in the treatment of schizophrenia. CNS Drugs 17 (2003) 1081-1091
53. Richardson A.J. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids 70 (2004) 383-390